Knoll, Abbott likely to be affected by NPPA decision - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  
  • Home
  • Outlook Arena
  • Feb 14, 2000 - Knoll, Abbott likely to be affected by NPPA decision

Knoll, Abbott likely to be affected by NPPA decision

Feb 14, 2000

The prices of formulations using ibuprofen and erythromycin are likely to be reduced. The price rise is expected to be in the range of around 20%. The NPPA was set up in 1997 as the official body to administer the Drug Price Control Order (DPCO). It announces price revisions almost every month. Most of the times the recommendations do affect the multinational pharmaceutical companies since they are the ones which have a relatively higher proportion (anywhere between 45-60%) of the revenues accruing from products under price control.

The companies affected are Abbott Laboratories, Knoll Pharmaceutical, Hoechst Marion Roussel, and Alembic Chemicals. Abbott Laboratories is the market leader in the erythromycin segment with a market share of 35% plus. Similarly Knoll derives more than 20% of its revenues from Brufen (its ibuprofen based formulation) and is a market leader in the segment.

The formulation prices are being reduced on the basis of the fact that the bulk drug prices of the respective formulations have dropped.

Equitymaster requests your view! Post a comment on "Knoll, Abbott likely to be affected by NPPA decision". Click here!


More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in PHARMACIA HEALTH. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks